Clinical response to the CD95-ligand inhibitor asunercept is defined by a pro-inflammatory serum cytokine profile
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
8 December 2020
|
| In: |
Cancers
Year: 2021, Jahrgang: 13, Heft: 4, Pages: 1-23 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers12123683 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers12123683 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/12/12/3683 
|
| Verfasserangaben: | Aleksandar Radujkovic, Tobias Boch, Florian Nolte, Daniel Nowak, Claudia Kunz, Alexandra Gieffers, Carsten Müller-Tidow, Peter Dreger, Wolf-Karsten Hofmann and Thomas Luft |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1789195365 | ||
| 003 | DE-627 | ||
| 005 | 20220820125044.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220210s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers12123683 |2 doi | |
| 035 | |a (DE-627)1789195365 | ||
| 035 | |a (DE-599)KXP1789195365 | ||
| 035 | |a (OCoLC)1341441596 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Radujković, Aleksandar |d 1980- |e VerfasserIn |0 (DE-588)132951320 |0 (DE-627)529183536 |0 (DE-576)299523721 |4 aut | |
| 245 | 1 | 0 | |a Clinical response to the CD95-ligand inhibitor asunercept is defined by a pro-inflammatory serum cytokine profile |c Aleksandar Radujkovic, Tobias Boch, Florian Nolte, Daniel Nowak, Claudia Kunz, Alexandra Gieffers, Carsten Müller-Tidow, Peter Dreger, Wolf-Karsten Hofmann and Thomas Luft |
| 246 | 3 | 0 | |a ninety-five |
| 264 | 1 | |c 8 December 2020 | |
| 300 | |a 23 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 10.02.2022 | ||
| 700 | 1 | |a Boch, Tobias |d 1984- |e VerfasserIn |0 (DE-588)1052922015 |0 (DE-627)789313847 |0 (DE-576)40866732X |4 aut | |
| 700 | 1 | |a Nolte, Florian |d 1976- |e VerfasserIn |0 (DE-588)1033390348 |0 (DE-627)741150433 |0 (DE-576)380987031 |4 aut | |
| 700 | 1 | |a Nowak, Daniel |d 1976- |e VerfasserIn |0 (DE-588)131932063 |0 (DE-627)51618041X |0 (DE-576)298844540 |4 aut | |
| 700 | 1 | |a Kunz, Claudia-Elisabeth |d 1972- |e VerfasserIn |0 (DE-588)122542568 |0 (DE-627)70594557X |0 (DE-576)293315590 |4 aut | |
| 700 | 1 | |a Gieffers, Alexandra |e VerfasserIn |4 aut | |
| 700 | 1 | |a Müller-Tidow, Carsten |d 1968- |e VerfasserIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 aut | |
| 700 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 700 | 1 | |a Hofmann, Wolf-Karsten |d 1967- |e VerfasserIn |0 (DE-588)114154635 |0 (DE-627)691208751 |0 (DE-576)351568336 |4 aut | |
| 700 | 1 | |a Luft, Thomas |e VerfasserIn |0 (DE-588)1078976309 |0 (DE-627)839996969 |0 (DE-576)452120659 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d Basel : MDPI, 2009 |g 13(2021), 4, Artikel-ID 827, Seite 1-23 |h Online-Ressource |w (DE-627)614095670 |w (DE-600)2527080-1 |w (DE-576)313958548 |x 2072-6694 |7 nnas |a Clinical response to the CD95-ligand inhibitor asunercept is defined by a pro-inflammatory serum cytokine profile |
| 773 | 1 | 8 | |g volume:13 |g year:2021 |g number:4 |g elocationid:827 |g pages:1-23 |g extent:23 |a Clinical response to the CD95-ligand inhibitor asunercept is defined by a pro-inflammatory serum cytokine profile |
| 856 | 4 | 0 | |u https://doi.org/10.3390/cancers12123683 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2072-6694/12/12/3683 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220210 | ||
| 993 | |a Article | ||
| 998 | |g 1078976309 |a Luft, Thomas |m 1078976309:Luft, Thomas |d 910000 |d 910100 |d 50000 |e 910000PL1078976309 |e 910100PL1078976309 |e 50000PL1078976309 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 10 |y j | ||
| 998 | |g 114154635 |a Hofmann, Wolf-Karsten |m 114154635:Hofmann, Wolf-Karsten |d 60000 |d 61200 |e 60000PH114154635 |e 61200PH114154635 |k 0/60000/ |k 1/60000/61200/ |p 9 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 910000 |d 910100 |e 910000PD1028891881 |e 910100PD1028891881 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 998 | |g 1015101798 |a Müller-Tidow, Carsten |m 1015101798:Müller-Tidow, Carsten |d 910000 |d 910100 |e 910000PM1015101798 |e 910100PM1015101798 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 131932063 |a Nowak, Daniel |m 131932063:Nowak, Daniel |d 60000 |d 61200 |e 60000PN131932063 |e 61200PN131932063 |k 0/60000/ |k 1/60000/61200/ |p 4 | ||
| 998 | |g 1033390348 |a Nolte, Florian |m 1033390348:Nolte, Florian |d 60000 |d 61200 |e 60000PN1033390348 |e 61200PN1033390348 |k 0/60000/ |k 1/60000/61200/ |p 3 | ||
| 998 | |g 1052922015 |a Boch, Tobias |m 1052922015:Boch, Tobias |d 60000 |d 61200 |e 60000PB1052922015 |e 61200PB1052922015 |k 0/60000/ |k 1/60000/61200/ |p 2 | ||
| 998 | |g 132951320 |a Radujković, Aleksandar |m 132951320:Radujković, Aleksandar |d 910000 |d 910100 |d 50000 |e 910000PR132951320 |e 910100PR132951320 |e 50000PR132951320 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1789195365 |e 4055510144 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"pubHistory":["1.2009 -"],"id":{"issn":["2072-6694"],"eki":["614095670"],"zdb":["2527080-1"]},"part":{"year":"2021","volume":"13","pages":"1-23","text":"13(2021), 4, Artikel-ID 827, Seite 1-23","extent":"23","issue":"4"},"origin":[{"dateIssuedDisp":"2009-","dateIssuedKey":"2009","publisherPlace":"Basel","publisher":"MDPI"}],"title":[{"title":"Cancers","title_sort":"Cancers"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 27.05.2020"],"recId":"614095670","physDesc":[{"extent":"Online-Ressource"}],"disp":"Clinical response to the CD95-ligand inhibitor asunercept is defined by a pro-inflammatory serum cytokine profileCancers"}],"person":[{"display":"Radujković, Aleksandar","given":"Aleksandar","role":"aut","family":"Radujković"},{"display":"Boch, Tobias","family":"Boch","given":"Tobias","role":"aut"},{"role":"aut","given":"Florian","family":"Nolte","display":"Nolte, Florian"},{"role":"aut","given":"Daniel","family":"Nowak","display":"Nowak, Daniel"},{"role":"aut","given":"Claudia-Elisabeth","family":"Kunz","display":"Kunz, Claudia-Elisabeth"},{"family":"Gieffers","given":"Alexandra","role":"aut","display":"Gieffers, Alexandra"},{"given":"Carsten","role":"aut","family":"Müller-Tidow","display":"Müller-Tidow, Carsten"},{"family":"Dreger","given":"Peter","role":"aut","display":"Dreger, Peter"},{"display":"Hofmann, Wolf-Karsten","given":"Wolf-Karsten","role":"aut","family":"Hofmann"},{"family":"Luft","role":"aut","given":"Thomas","display":"Luft, Thomas"}],"origin":[{"dateIssuedDisp":"8 December 2020","dateIssuedKey":"2020"}],"title":[{"title_sort":"Clinical response to the CD95-ligand inhibitor asunercept is defined by a pro-inflammatory serum cytokine profile","title":"Clinical response to the CD95-ligand inhibitor asunercept is defined by a pro-inflammatory serum cytokine profile"}],"note":["Gesehen am 10.02.2022"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1789195365","physDesc":[{"extent":"23 S."}],"name":{"displayForm":["Aleksandar Radujkovic, Tobias Boch, Florian Nolte, Daniel Nowak, Claudia Kunz, Alexandra Gieffers, Carsten Müller-Tidow, Peter Dreger, Wolf-Karsten Hofmann and Thomas Luft"]},"id":{"doi":["10.3390/cancers12123683"],"eki":["1789195365"]}} | ||
| SRT | |a RADUJKOVICCLINICALRE8202 | ||